ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity toHDACInhibitors across Tumor Types
Anderly C Chueh, Janson WT Tse, Michael Dickinson, Paul Ioannidis, Laura Jenkins, Lars Togel, BeeShin Tan, Ian Luk, Mercedes Davalos-Salas, Rebecca Nightingale, Matthew R Thompson, Bryan RG Williams, Guillaume Lessene, Erinna F Lee, Walter D Fairlie, Amardeep S Dhillon, John M Mariadason
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2017
Awarded by National Health and Medical Research Council (NHMRC) of Australia
Awarded by National Institutes of Health
Awarded by Australian Research Council Future Fellowship
Awarded by NHMRC Senior Research Fellowship
This study was funded by the National Health and Medical Research Council (NHMRC) of Australia (1008833 and 1066665), The National Institutes of Health (NIH1RO1 CA123316), an Australian Research Council Future Fellowship (FT0992234), an NHMRC Senior Research Fellowship (1046092) to J.M. Mariadason, Ludwig Cancer Research, and the Operational Infrastructure Support Program, Victorian Government, Australia. J.W.T. Tse was supported by an Australian Postgraduate Award.